Vision after Clareon Vivity versus PureSee extended‑depth‑of‑focus lens implants
Official title: Visual Performance of Clareon® Vivity® and PureSee® Intraocular Lenses in Patients Undergoing Cataract Surgery
Run by OMIQ Research · NCT07165197 · Data updated 2026-11-12
This study will test whether two extended‑depth‑of‑focus intraocular lenses (Clareon Vivity and PureSee) give good vision for people aged 50 and older having cataract surgery in both eyes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | OMIQ Research Research network |
| Locations | 1 site (Sant Cugat del Vallès, Barcelona) |
| Status | Recruiting |
| Started | June 27, 2025 |
| Main results expected | March 2026 |
| Study ends | March 2026 |
| Registry record updated | September 10, 2025 |
| Trial ID | NCT07165197 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 50 or older with bilateral age-related cataracts, minimal other eye disease, and biometry that allows emmetropic correction with the available IOL powers.
✕Probably not a fit
Patients with significant corneal, macular, or optic nerve disease, irregular astigmatism, prior refractive/corneal/retinal/glaucoma surgery, amblyopia, or whose IOL power needs fall outside the lens ranges are unlikely to benefit in this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial enrolls adults aged 50 or older undergoing bilateral phacoemulsification cataract surgery and implants either the Clareon Vivity or the PureSee extended depth of focus (EDOF) intraocular lens in both eyes. Participants will be followed at scheduled visits to measure visual performance outcomes such as distance, intermediate and near visual acuity, contrast sensitivity, and patient‑reported spectacle dependence and visual disturbances. Key exclusions include prior corneal, refractive, retinal or glaucoma surgery, significant ocular surface, corneal, macular or optic nerve disease, irregular astigmatism, amblyopia, or IOL power requirements outside the available lens ranges. The trial is conducted at OMIQ Research in Sant Cugat del Vallès, Barcelona, and will cap inclusion of low astigmatism cases requiring toric-equivalent correction to a small number per group.
Why it matters
Potential benefit: If successful, these lenses could provide a broader range of clear vision and reduce reliance on glasses after cataract surgery.
How similar studies have gone: Other studies of EDOF IOLs, including published data on the Vivity lens, have shown improved intermediate vision and reduced spectacle dependence, but direct head‑to‑head comparisons between these two specific lenses are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients of any sex and race aged 50 years or older * Patients undergoing bilateral age-related cataract surgery with a lens opacity grade 3 or higher in the LOCS III grading scale * Willing to receive implantation of an EDOF IOL * Willing to sign the informed consent and attend the study visits Exclusion Criteria: * Requirement of a spherical or toric power of the IOL to achieve emmetropia beyond the available range of either of the two lenses * The number of patients included with low astigmatism that require an equivalent to a T2 toric IOL will be capped to 10 patients/group * Irregular astigmatism * Contact lens wear in the previous 3 weeks before biometry * Moderate or severe ocular surface, corneal, macular or optic nerve disease that in opinion of the investigator precludes the desired functional results * History of previous refractive, cornea, retina or glaucoma surgery * Eyes with a clear lens demanding a refractive lens exchange * Amblyopia in any eye * Significant previous ocular trauma * Pregnancy * A systemic condition that, in the opinion of the investigator, precludes the reliable assessments required in the study (i.e., dementia) or participation in the study (i.e., severe mobility problems).
Where it's running
-
OMIQ Research
Sant Cugat del Vallès, Barcelona, Spain Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rotational Stability of the Acunex Vario Toric
This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
MiLOOP-assisted cataract surgery for dense cataracts
In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.
-
Visual adaptation and quality of life after different IOL implantation options
This study follows adults who have cataracts and receive bilateral multifocal or mixed IOLs to see how their vision and daily life improve over 6 months.
-
Corneal Biomechanics and Surgical Astigmatism after Cataract Surgery in Pseudoexfoliation
This study tests how the cornea's biomechanical properties before cataract surgery relate to the amount of blinking surgically induced astigmatism, comparing people with pseudoexfoliation to those without.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.